These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19267157)

  • 1. Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy.
    Hsu FM; Lee YC; Lee JM; Hsu CH; Lin CC; Tsai YC; Wu JK; Cheng JC
    Ann Surg Oncol; 2009 Jun; 16(6):1669-77. PubMed ID: 19267157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
    Allen AM; Czerminska M; Jänne PA; Sugarbaker DJ; Bueno R; Harris JR; Court L; Baldini EH
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):640-5. PubMed ID: 16751058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
    Wang SL; Liao Z; Vaporciyan AA; Tucker SL; Liu H; Wei X; Swisher S; Ajani JA; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):692-9. PubMed ID: 16242257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.
    Mell LK; Kochanski JD; Roeske JC; Haslam JJ; Mehta N; Yamada SD; Hurteau JA; Collins YC; Lengyel E; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1356-65. PubMed ID: 16757127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
    Tucker SL; Liu HH; Wang S; Wei X; Liao Z; Komaki R; Cox JD; Mohan R
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):754-61. PubMed ID: 16965865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
    Rice DC; Smythe WR; Liao Z; Guerrero T; Chang JY; McAleer MF; Jeter MD; Correa A; Vaporciyan AA; Liu HH; Komaki R; Forster KM; Stevens CW
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):350-7. PubMed ID: 17467922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer.
    Watkins JM; Wahlquist AE; Shirai K; Garrett-Mayer E; Aguero EG; Fortney JA; Sherman CA; Sharma AK
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1108-13. PubMed ID: 19084345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer.
    Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Nishida T; Mori M; Doki Y
    J Surg Oncol; 2009 Nov; 100(6):442-6. PubMed ID: 19653262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Transforming Growth Factor-β1 Change After Neoadjuvant Chemoradiation Therapy Is Associated With Postoperative Pulmonary Complications in Esophageal Cancer Patients Undergoing Combined Modality Therapy.
    Lu SL; Hsu FM; Tsai CL; Wu JK; Lee JM; Huang PM; Hsu CH; Koong AC; Chang DT; Cheng JC
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1023-31. PubMed ID: 26475065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlations of preoperative pulmonary function tests for esophageal cancer to postoperative acute respiratory distress syndrome].
    Liu LX; Hu ZJ; Zhao C
    Ai Zheng; 2006 Mar; 25(3):335-8. PubMed ID: 16536989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
    J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma.
    Beriwal S; Coon D; Heron DE; Kelley JL; Edwards RP; Sukumvanich P; Zorn KK; Krivak TC
    Gynecol Oncol; 2008 May; 109(2):291-5. PubMed ID: 18455637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma.
    Kristensen CA; Nøttrup TJ; Berthelsen AK; Kjaer-Kristoffersen F; Ravn J; Sørensen JB; Engelholm SA
    Radiother Oncol; 2009 Jul; 92(1):96-9. PubMed ID: 19364621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy.
    Reynolds JV; Ravi N; Hollywood D; Kennedy MJ; Rowley S; Ryan A; Hughes N; Carey M; Byrne P
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):549-55. PubMed ID: 16935109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolic events before esophagectomy for esophageal cancer do not result in worse outcomes.
    Teman NR; Silski L; Zhao L; Kober M; Urba SC; Orringer MB; Chang AC; Lin J; Reddy RM
    Ann Thorac Surg; 2012 Oct; 94(4):1118-24; discussion 1124-5. PubMed ID: 22858275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory function after esophagectomy for patients with esophageal cancer.
    Ikeguchi M; Maeta M; Kaibara N
    Hepatogastroenterology; 2002; 49(47):1284-6. PubMed ID: 12239925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy.
    Wei X; Liu HH; Tucker SL; Wang S; Mohan R; Cox JD; Komaki R; Liao Z
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):707-14. PubMed ID: 18191334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Mell LK; Schomas DA; Salama JK; Devisetty K; Aydogan B; Miller RC; Jani AB; Kindler HL; Mundt AJ; Roeske JC; Chmura SJ
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1431-7. PubMed ID: 17996390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of esophageal stenosis after simultaneous modulated accelerated radiation therapy and chemotherapy for head and neck cancer.
    Lawson JD; Otto K; Grist W; Johnstone PA
    Am J Otolaryngol; 2008; 29(1):13-9. PubMed ID: 18061826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.